The current achievements in treating glioblastoma (GBM) patients are not sufficient because
many challenges exist, such as tumor heterogeneity, the blood brain barrier, glioma stem …

Simple Summary This review describes in a very detailed and exhaustive approach the
literature of these last 20 years on glioblastoma targeted therapies in Phases II-IV of 257 …

Sex differences in the incidence and outcome of human disease are broadly recognized but,
in most cases, not sufficiently understood to enable sex-specific approaches to treatment …

Objective To identify the frequency and characteristics of long-term survivors of
glioblastoma. Patients and Methods Using all cases of glioblastoma with histopathological …

Gliomas represent the majority of malignant central nervous system tumors, with the most
aggressive subtype, glioblastoma, accounting for almost 57% of this entity. Type of glioma …

Background Glioblastoma (GBM) is a highly malignant brain tumor with poor survival and
prognosis. Randomized trials have demonstrated that chemotherapy improves survival in …

OBJECTIVE The present study was designed to explore the association between facility type
(academic center [AC] vs non-AC), facility volume (high-volume facility [HVF] vs low-volume …

OBJECTIVE Intraoperative MRI (iMRI) is used in the surgical treatment of glioblastoma, with
uncertain effects on outcomes. The authors evaluated the impact of iMRI on extent of …

OBJECTIVE Genomic analysis in neurooncology has underscored the importance of
understanding the patterns of survival in different molecular subtypes within gliomas and …

Purpose To evaluate the efficacy of three‐dimensional (3D) segmentation‐based radiomics
analysis of multiparametric MRI combined with proton magnetic resonance spectroscopy …